Truly wonderful team! Pleas keep up the great work of behalf of our patients.
~Dr. Naveen Pemmaraju, MD Anderson
As part of our coverage from the 2016 American Society of Hematology (ASH) annual meeting, MPN experts Dr. Catriona Jamieson, Dr. John Mascarenhas, Dr. Stephen Oh and our own Andrew Schorr, gathered to discuss the latest updates on treatment and research.
What factors should you consider when deciding to undergo a stem cell transplant (SCT) for myelofibrosis? Hear firsthand experience from Bo, who was diagnosed with an MPN at age 36.
Dr. Srdan Verstovsek of MD Anderson Cancer Center shares a comprehensive overview of the MPN treatments being discussed at ASH 2016.